The cost-effectiveness of pioglitazone in combination with metformin in the treatment of type 2 diabetes mellitus in Scotland

被引：1
|
作者：
Stynes, G
Tilden, D
Swift, M
Cockle, S
Haycox, A
Aristides, M
机构：
[1] M TAG Ltd, Hammersmith, England
[2] Takeda UK Ltd, High Wycombe, Bucks, England
[3] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65953-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [1] Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
    Holland, Daniel Q.
    Neumiller, Joshua J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 277 - 288
  • [2] COST-EFFECTIVENESS OF FIXED-DOSE COMBINATION (FDC) OF VILDAGLIPTIN/METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN MEXICO
    Lemus, A.
    Jimenez Aranda, P.
    VALUE IN HEALTH, 2013, 16 (07) : A689 - A689
  • [3] COST EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN IN COMBINATION WITH METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN POLAND
    Szmurlo, D.
    Drzal, R.
    Plisko, R.
    Schubert, A.
    Skrzekowska-Baran, I
    VALUE IN HEALTH, 2014, 17 (07) : A346 - A346
  • [4] Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus
    Rodriguez, Angel
    Reviriego, Jesus
    Polavieja, Pepa
    Mesa, Jordi
    MEDICINA CLINICA, 2008, 131 (19): : 721 - 730
  • [5] Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study
    Rojas, Giovanni
    Nunes, Altacilio
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 33 - 39
  • [6] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Nicholas Tentolouris
    Georgia Kourlaba
    Nikos Maniadakis
    Clinical Drug Investigation, 2016, 36 : 649 - 659
  • [7] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Tzanetakos, Charalampos
    Tentolouris, Nicholas
    Kourlaba, Georgia
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2016, 36 (08) : 649 - 659
  • [8] Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK
    Sophie Beale
    Adrian Bagust
    Arran T. Shearer
    Alan Martin
    Lisa Hulme
    PharmacoEconomics, 2006, 24 (Suppl 1) : 21 - 34
  • [9] THE COST-EFFECTIVENESS OF SAXAGLIPTIN WHEN ADED TO METFORMIN AND SULPHONYLUREA IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SPAIN
    Sanchez-Covisa, J.
    Franch, J.
    Mauricio, D.
    Lopez-Martinez, N.
    Chuang, L. H.
    Capel, M.
    VALUE IN HEALTH, 2014, 17 (07) : A350 - A350
  • [10] The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus
    Charokopou, M.
    McEwan, P.
    Lister, S.
    Callan, L.
    Bergenheim, K.
    Tolley, K.
    Postema, R.
    Townsend, R.
    Roudaut, M.
    DIABETIC MEDICINE, 2015, 32 (07) : 890 - 898
12345